Claudio Faria, PharmD, MPH

Director of Health Economics and
Outcomes Research
Eisai Inc
Woodcliff Lake, NJ

Director of Health Economics and Outcomes Research
Eisai Inc, Woodcliff Lake, NJ

Authored Items

Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer

Albert Tzeel, MD, MHSA, CPE, FAAPL, Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA

October 2014 Vol 7, No 7 in Clinical

The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature

Michael S. Broder, MD, MSHS, Atheer Kaddis, PharmD, Claudio Faria, PharmD, MPH, Annette Powers, PharmD, MBA, Jehangeer Sunderji, MD, Dasha Cherepanov, PhD

May 2014 Vol 7, No 3 in Business

Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis

Claudio Faria, PharmD, MPH, Curtis Wander, PharmD, Xuan Li, MS, Norman Nagl, PhD, Ali McBride, PharmD, MS

January/February 2014 Vol 7, No 1 in Clinical

Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care

Annette Powers, PharmD, MBA, Claudio Faria, PharmD, MPH, Eunice Chang, PhD, Dasha Cherepanov, PhD, Jeffrey A. Bourret, PharmD

November/December 2012 Vol 5, No 7 in Business

Last modified: March 12, 2014

• 
• 
• 

• 
• 
• 

• 
•